Success Metrics

Clinical Success Rate

100.0%

Based on 9 completed trials

Completion Rate

100%(9/9)

Active Trials

0(0%)

Results Posted

67%(6 trials)

Phase Distribution

Ph phase_4

33%

Ph phase_3

Ph phase_2

17%

Ph phase_1

33%

Ph not_applicable

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution12 total trials

Phase 1Safety & dosage

4(33.3%)

Phase 2Efficacy & side effects

2(16.7%)

Phase 3Large-scale testing

1(8.3%)

Phase 4Post-market surveillance

4(33.3%)

N/ANon-phased studies

1(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(9)

Terminated(2)

Other(1)

Detailed Status

Completed9

Withdrawn2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 14 (33.3%)

Phase 22 (16.7%)

Phase 31 (8.3%)

Phase 44 (33.3%)

N/A1 (8.3%)

Trials by Status

unknown18%

withdrawn217%

completed975%

Recent Activity

0 active trials

Showing 5 of 12

unknownphase_1

Intra-anal Oxymetazoline in Healthy Adult Volunteers

NCT03529487

completedphase_3

An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea

NCT03352323

completedphase_4

Comparing Blood Loss and Visualization After the Preoperative Use of Topical 0.05% Oxymetazoline Versus 1:1000 Epinephrine Prior to Endoscopic Sinus Surgery

NCT03228914

completedphase_1

TransMEM Gas Exchange -- Project 1, Aim 2

NCT01925729

completedphase_1

A Study of Nasal Glucagon in Participants With a Common Cold

NCT02778100

View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials

NCT03529487Phase 1

Intra-anal Oxymetazoline in Healthy Adult Volunteers

Unknown

NCT03352323Phase 3

An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea

Completed

NCT03228914Phase 4

Comparing Blood Loss and Visualization After the Preoperative Use of Topical 0.05% Oxymetazoline Versus 1:1000 Epinephrine Prior to Endoscopic Sinus Surgery

Completed

NCT01925729Phase 1

TransMEM Gas Exchange -- Project 1, Aim 2

Completed

NCT02778100Phase 1

A Study of Nasal Glucagon in Participants With a Common Cold

Completed

NCT02453841Not Applicable

Prospective Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption

Completed

NCT00846326Phase 4

Preventing Tolerance to Oxymetazoline in Allergic Rhinitis

Withdrawn

NCT02154334Phase 1

Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal Esketamine

Completed

NCT01986582Phase 2

NoAL (HPMC) in Combination With Oxymetazoline in Patients With Allergic Rhinitis

Completed

NCT02062996Phase 2

Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption

Withdrawn

NCT01847131Phase 4

Effectiveness of Oxymetazoline Added on Nasal Steroid in Rhinitis With Persistent Nasal Obstruction

Completed

NCT00584987Phase 4

Intranasal Steroids and Oxymetazoline in Allergic Rhinitis